Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1

Interventions

nilotinib 3bosutinib 2Imatinib Mesylate 2Filgrastim 2Dasatinib 2Cytogenetic Analysis 2ruxolitinib 1pembrolizumab 1liposomal amphotericin B 1asciminib 1Watchful Waiting 1Vancomycin 1Tyrosine Kinase Inhibitors 1Transplantation 1Tazobactam 1Specimen Handling 1Polymerase Chain Reaction 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Moxifloxacin 1Morphine 1Microscopy 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Idarubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myeloid, Chronic-Phase × Transplantation × Clear all
NCT00450450 2022-04-28

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Children's Oncology Group

Phase 3 Completed
27 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡